A bioengineering approach to Schlemm's canal-like stem cell differentiation for in vitro glaucoma drug screening
- 23 January 2020
- journal article
- research article
- Published by Elsevier BV in Acta Biomaterialia
- Vol. 105, 203-213
- https://doi.org/10.1016/j.actbio.2020.01.033
Abstract
No abstract availableKeywords
Funding Information
- National Eye Institute
- National Science Foundation
This publication has 62 references indexed in Scilit:
- Consensus recommendations for trabecular meshwork cell isolation, characterization and cultureExperimental Eye Research, 2018
- Bioengineered glaucomatous 3D human trabecular meshwork as an in vitro disease modelBiotechnology & Bioengineering, 2015
- Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysisBritish Journal of Ophthalmology, 2015
- In VitroInduction of Human Adipose-Derived Stem Cells into Lymphatic Endothelial-Like CellsCellular Reprogramming, 2015
- Aqueous Humor Outflow: What Do We Know? Where Will It Lead Us?Investigative Ophthalmology & Visual Science, 2006
- Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cellsBiochemical and Biophysical Research Communications, 2006
- Endothelia of Schlemm's canal and trabecular meshwork: distinct molecular, functional, and anatomic featuresAmerican Journal of Physiology-Cell Physiology, 2004
- Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytesThe Annals of Thoracic Surgery, 2003
- Human Schlemm's canal cells express the endothelial adherens proteins, VE-cadherin and PECAM-1.Current Eye Research, 2002